Marshall Wace, LLP Johnson & Johnson Transaction History

Marshall Wace, LLP

$74.4 Billion
Q1 2025

A detailed history of Marshall Wace, LLP transactions in Johnson & Johnson stock. As of the latest transaction made, Marshall Wace, LLP holds 912,884 shares of JNJ stock, worth $142 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

912,884

Previous 4,057,710 77.5%

Holding current value

$142 Million

Previous $587 Million 74.2%

% of portfolio

0.2%

Previous 0.75%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$142.06 - $167.7 $447 Million - $527 Million	-3,144,826 Reduced 77.5%	912,884 $151 Million
Q4 2024 Feb 13, 2025	SELL	$143.34 - $165.86 $174 Million - $201 Million	-1,213,797 Reduced 23.03%	4,057,710 $587 Million
Q3 2024 Nov 14, 2024	BUY	$145.48 - $167.38 $202 Million - $232 Million	1,386,545 Added 35.69%	5,271,507 $854 Million
Q2 2024 Aug 14, 2024	BUY	$144.38 - $157.78 $468 Million - $512 Million	3,244,862 Added 506.93%	3,884,962 $568 Million
Q1 2024 May 15, 2024	BUY	$155.22 - $162.74 $83.6 Million - $87.7 Million	538,800 Added 531.89%	640,100 $101 Million
Q4 2023 Feb 14, 2024	BUY	$145.6 - $158.88 $14.7 Million - $16.1 Million	101,300 New	101,300 $15.9 Million
Q2 2023 Aug 14, 2023	BUY	$154.35 - $166.11 $201 Million - $216 Million	1,301,450 Added 311.4%	1,719,389 $285 Million
Q1 2023 May 15, 2023	SELL	$151.05 - $180.26 $4.75 Million - $5.67 Million	-31,474 Reduced 7.0%	417,939 $64.8 Million
Q4 2022 Feb 14, 2023	SELL	$160.2 - $179.79 $289 Million - $325 Million	-1,804,959 Reduced 80.06%	449,413 $79.4 Million
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $103 Million - $115 Million	-638,948 Reduced 22.08%	2,254,372 $368 Million
Q2 2022 Aug 15, 2022	BUY	$168.19 - $186.01 $156 Million - $173 Million	930,025 Added 47.37%	2,893,320 $514 Million
Q1 2022 May 16, 2022	SELL	$158.14 - $179.59 $73.2 Million - $83.1 Million	-462,856 Reduced 19.08%	1,963,295 $348 Million
Q4 2021 Feb 14, 2022	BUY	$155.93 - $173.01 $309 Million - $343 Million	1,981,275 Added 445.35%	2,426,151 $415 Million
Q3 2021 Nov 15, 2021	BUY	$161.5 - $179.47 $5.66 Million - $6.29 Million	35,052 Added 8.55%	444,876 $71.8 Million
Q2 2021 Aug 13, 2021	BUY	$159.48 - $171.07 $55.8 Million - $59.8 Million	349,717 Added 581.82%	409,824 $67.5 Million
Q1 2021 May 17, 2021	BUY	$153.07 - $170.48 $9.2 Million - $10.2 Million	60,107 New	60,107 $9.88 Million
Q4 2020 Feb 16, 2021	SELL	$137.11 - $157.38 $2.23 Million - $2.56 Million	-16,295 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$140.38 - $153.83 $25.1 Million - $27.5 Million	-178,924 Reduced 91.65%	16,295 $2.43 Million
Q2 2020 Aug 13, 2020	SELL	$128.81 - $155.51 $71 Million - $85.8 Million	-551,428 Reduced 73.85%	195,219 $27.5 Million
Q1 2020 May 15, 2020	BUY	$111.14 - $153.99 $21.3 Million - $29.6 Million	191,984 Added 34.61%	746,647 $97.9 Million
Q4 2019 Feb 14, 2020	SELL	$127.5 - $146.44 $17.1 Million - $19.7 Million	-134,322 Reduced 19.5%	554,663 $80.9 Million
Q3 2019 Nov 14, 2019	BUY	$126.95 - $142.14 $87.5 Million - $97.9 Million	688,985 New	688,985 $89.1 Million
Q2 2019 Aug 14, 2019	SELL	$131.15 - $144.24 $13.8 Million - $15.2 Million	-105,502 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$125.72 - $139.79 $12.9 Million - $14.4 Million	102,804 Added 3810.38%	105,502 $14.7 Million
Q4 2018 Feb 14, 2019	BUY	$122.84 - $147.84 $331,422 - $398,872	2,698 New	2,698 $348,000
Q2 2018 Aug 14, 2018	SELL	$119.4 - $131.76 $2.46 Million - $2.71 Million	-20,602 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$125.1 - $148.14 $378,427 - $448,123	3,025 Added 17.21%	20,602 $2.64 Million
Q4 2017 Feb 14, 2018	BUY	$131.22 - $143.62 $252,860 - $276,755	1,927 Added 12.31%	17,577 $2.46 Million
Q3 2017 Nov 13, 2017	BUY	$129.47 - $135.38 $2.03 Million - $2.12 Million	15,650	15,650 $2.04 Million

Others Institutions Holding JNJ

# of Institutions

4,654

Shares Held

1.73B

Call Options Held

25M

Put Options Held

15.1M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $406B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Johnson & Johnson Transaction History